S&P 500   5,079.74 (-0.85%)
DOW   37,825.87 (-0.41%)
QQQ   431.46 (-1.55%)
AAPL   173.71 (-1.61%)
MSFT   414.81 (-1.68%)
META   498.44 (-2.63%)
GOOGL   155.44 (-1.45%)
AMZN   183.23 (-1.56%)
TSLA   162.84 (-4.80%)
NVDA   865.68 (-1.83%)
AMD   159.44 (-2.35%)
NIO   3.84 (-6.57%)
BABA   70.44 (-1.19%)
T   16.19 (-0.74%)
F   12.30 (-2.46%)
MU   121.30 (-1.00%)
GE   153.22 (-0.91%)
CGC   7.16 (-8.21%)
DIS   113.03 (-0.86%)
AMC   2.58 (-2.64%)
PFE   25.97 (+0.43%)
PYPL   63.70 (-1.38%)
XOM   119.61 (-0.63%)
S&P 500   5,079.74 (-0.85%)
DOW   37,825.87 (-0.41%)
QQQ   431.46 (-1.55%)
AAPL   173.71 (-1.61%)
MSFT   414.81 (-1.68%)
META   498.44 (-2.63%)
GOOGL   155.44 (-1.45%)
AMZN   183.23 (-1.56%)
TSLA   162.84 (-4.80%)
NVDA   865.68 (-1.83%)
AMD   159.44 (-2.35%)
NIO   3.84 (-6.57%)
BABA   70.44 (-1.19%)
T   16.19 (-0.74%)
F   12.30 (-2.46%)
MU   121.30 (-1.00%)
GE   153.22 (-0.91%)
CGC   7.16 (-8.21%)
DIS   113.03 (-0.86%)
AMC   2.58 (-2.64%)
PFE   25.97 (+0.43%)
PYPL   63.70 (-1.38%)
XOM   119.61 (-0.63%)
S&P 500   5,079.74 (-0.85%)
DOW   37,825.87 (-0.41%)
QQQ   431.46 (-1.55%)
AAPL   173.71 (-1.61%)
MSFT   414.81 (-1.68%)
META   498.44 (-2.63%)
GOOGL   155.44 (-1.45%)
AMZN   183.23 (-1.56%)
TSLA   162.84 (-4.80%)
NVDA   865.68 (-1.83%)
AMD   159.44 (-2.35%)
NIO   3.84 (-6.57%)
BABA   70.44 (-1.19%)
T   16.19 (-0.74%)
F   12.30 (-2.46%)
MU   121.30 (-1.00%)
GE   153.22 (-0.91%)
CGC   7.16 (-8.21%)
DIS   113.03 (-0.86%)
AMC   2.58 (-2.64%)
PFE   25.97 (+0.43%)
PYPL   63.70 (-1.38%)
XOM   119.61 (-0.63%)
S&P 500   5,079.74 (-0.85%)
DOW   37,825.87 (-0.41%)
QQQ   431.46 (-1.55%)
AAPL   173.71 (-1.61%)
MSFT   414.81 (-1.68%)
META   498.44 (-2.63%)
GOOGL   155.44 (-1.45%)
AMZN   183.23 (-1.56%)
TSLA   162.84 (-4.80%)
NVDA   865.68 (-1.83%)
AMD   159.44 (-2.35%)
NIO   3.84 (-6.57%)
BABA   70.44 (-1.19%)
T   16.19 (-0.74%)
F   12.30 (-2.46%)
MU   121.30 (-1.00%)
GE   153.22 (-0.91%)
CGC   7.16 (-8.21%)
DIS   113.03 (-0.86%)
AMC   2.58 (-2.64%)
PFE   25.97 (+0.43%)
PYPL   63.70 (-1.38%)
XOM   119.61 (-0.63%)

Eterna Therapeutics (ERNA) News Today

$2.21
-0.03 (-1.34%)
(As of 12:10 PM ET)
SourceHeadline
MarketBeat logoContrasting Eterna Therapeutics (NASDAQ:ERNA) & PaxMedica (NASDAQ:PXMD)
americanbankingnews.com - April 9 at 1:52 AM
finance.yahoo.com logoQ4 2023 Cognition Therapeutics Inc Earnings Call
finance.yahoo.com - March 27 at 1:36 AM
msn.com logoViking Therapeutics' experimental tablet helps reduce weight in small study
msn.com - March 26 at 7:53 AM
investorplace.com logoERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023
investorplace.com - March 15 at 10:03 AM
benzinga.com logoEterna Therapeutics Stock (NASDAQ:ERNA) Dividends: History, Yield and Dates
benzinga.com - February 23 at 4:18 PM
finance.yahoo.com logoEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
finance.yahoo.com - February 20 at 1:20 PM
globenewswire.com logoEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
globenewswire.com - February 20 at 8:30 AM
msn.com logoEterna Therapeutics files to sell 18.2M shares for holders
msn.com - January 12 at 8:53 PM
finance.yahoo.com logoEterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
finance.yahoo.com - January 3 at 9:06 PM
finance.yahoo.com logoEterna Therapeutics Appoints Sanjeev Luther as President and CEO
finance.yahoo.com - December 21 at 12:45 PM
msn.com logoEterna Therapeutics names Sanjeev Luther as CEO
msn.com - December 20 at 7:56 PM
finance.yahoo.com logoEterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
finance.yahoo.com - December 20 at 7:56 PM
msn.com logoEterna Therapeutics launches convertible debt and warrant financing of up to $9.2M
msn.com - December 15 at 2:55 PM
finance.yahoo.com logoEterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
finance.yahoo.com - December 14 at 11:40 PM
markets.businessinsider.com logoTreadwell Announces Strategic Pipeline Prioritization and Leadership Transitions
markets.businessinsider.com - December 6 at 8:35 PM
marketbeat.com logo
marketbeat.com - December 6 at 2:17 PM
finance.yahoo.com logoEterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
finance.yahoo.com - November 1 at 1:58 PM
markets.businessinsider.com logoCalidi Biotherapeutics Names Andrew Jackson CFO
markets.businessinsider.com - October 30 at 10:42 AM
marketwatch.com logoCalidi Biotherapeutics Names Andrew Jackson Chief Financial Officer
marketwatch.com - October 30 at 10:42 AM
markets.businessinsider.com logoPositive Clinical Outcomes and Continued Genentech Support Bolster Buy Rating for Lineage Cell Therapeutics: An Analysis of OpRegen’s Potential
markets.businessinsider.com - October 5 at 8:08 AM
uk.finance.yahoo.com logoStem Cell Therapy Contract Manufacturing market is projected to grow at a CAGR of 12.4% by 2033: Visiongain
uk.finance.yahoo.com - September 13 at 9:53 AM
finance.yahoo.com logoInsider Stock Buying Reaches US$2.7m On Eterna Therapeutics
finance.yahoo.com - September 8 at 5:41 PM
finance.yahoo.com logoEterna Therapeutics Teams with Lineage Cell on Transplant Therapies
finance.yahoo.com - September 6 at 5:50 PM
finance.yahoo.com logoEterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
finance.yahoo.com - September 6 at 8:47 AM
finance.yahoo.com logoEterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
finance.yahoo.com - September 5 at 12:46 PM
finance.yahoo.com logoEterna Therapeutics Appoints Dorothy Clarke to Board of Directors
finance.yahoo.com - September 5 at 12:46 PM
finance.yahoo.com logoEterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing
finance.yahoo.com - July 18 at 12:30 PM
finance.yahoo.com logoEterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
finance.yahoo.com - July 11 at 8:58 AM
finance.yahoo.com logoEterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
finance.yahoo.com - May 24 at 10:45 AM
finance.yahoo.com logoEterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
finance.yahoo.com - May 17 at 1:11 PM
finance.yahoo.com logoEterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
finance.yahoo.com - May 4 at 12:41 PM
marketwatch.com logoEterna Therapeutics Shares Rise 11% After Offer for Exacis Biotherapeutics Assets
marketwatch.com - May 2 at 1:36 PM
finance.yahoo.com logoEterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
finance.yahoo.com - May 2 at 8:36 AM
marketwatch.com logoEterna Therapeutics Agrees to $10M Stock Purchase with Lincoln Park Capital
marketwatch.com - April 11 at 12:42 PM
finance.yahoo.com logoEterna Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for Up To $10 Million
finance.yahoo.com - April 11 at 12:42 PM
finance.yahoo.com logoJeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board
finance.yahoo.com - March 28 at 10:44 AM
seekingalpha.com logoERNA Eterna Therapeutics Inc.
seekingalpha.com - March 24 at 10:15 AM
finance.yahoo.com logoEterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
finance.yahoo.com - March 20 at 7:54 PM
finance.yahoo.com logoInsiders might want to re-evaluate their US$2.7m stock purchase as Eterna Therapeutics Inc. (NASDAQ:ERNA) drops to US$16m
finance.yahoo.com - March 16 at 8:20 AM
finance.yahoo.com logoTreadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
finance.yahoo.com - February 3 at 10:56 PM
msn.com logoEterna Therapeutics chief medical officer to resign
msn.com - January 26 at 5:40 PM
marketwatch.com logoEterna Therapeutics Names Matt Angel as Permanent President, CEO >ERNA
marketwatch.com - January 5 at 2:16 PM
msn.com logoEterna appoints Matt Angel as CEO, President
msn.com - January 4 at 1:58 PM
finance.yahoo.com logoEterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President
finance.yahoo.com - January 4 at 1:58 PM
finance.yahoo.com logoIn a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics
finance.yahoo.com - December 20 at 8:49 AM
msn.com logoWhat's Going On With Eterna Therapeutics Stock Today?
msn.com - December 9 at 6:21 PM
finance.yahoo.com logoEterna Therapeutics Announces Research Collaboration to Develop Advanced Gene-Edited iPS Cell Therapies
finance.yahoo.com - December 9 at 6:21 PM
marketbeat.com logo
marketbeat.com - December 7 at 9:43 AM
marketbeat.com logo
marketbeat.com - December 7 at 9:37 AM
marketbeat.com logo
marketbeat.com - October 19 at 11:12 AM
Get Eterna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter.

2024 Oil Boom (Ad)

Wall Street’s betting on new oil bull market… JP Morgan analysts have pegged the future price of oil at $380 per barrel. That would send oil companies skyrocketing.

All the details are right here

ERNA Media Mentions By Week

ERNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ERNA
News Sentiment

0.30

0.65

Average
Medical
News Sentiment

ERNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ERNA Articles
This Week

3

0

ERNA Articles
Average Week

Get Eterna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ERNA) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners